Skip to main content
Clinical Trials/CTRI/2017/02/007799
CTRI/2017/02/007799Completed未知

Is once daily oral iron supplementation as good as twice daily oral iron supplementation for correction of iron deficiency in subjects with stage G3-4 chronic kidney disease? - Nil

Dr Vivek Kumar0 sites80 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Iron deficiency defined as TSAT <30 % and serum ferritin <500 mg/L.
  • 2.Clinically stable course for last 3 months

Exclusion Criteria

  • 1.Blood haemoglobin <10 g/dl
  • 2.Current use or use within last 3 months of oral or intravenous iron preparations
  • 3.Known/ suspected diagnosis of autoimmune disease
  • 4.Past or present diagnosis of malignancy
  • 5.Known diagnosis of chronic liver disease
  • 6.History of any bleeding diathesis
  • 7.History of gastro-intestinal surgery
  • 8.Present or past diagnosis of peptic ulcer disease, gastro-intestinal bleeding or any form of gastro-intestinal disease predisposing to malabsorption
  • 9.Currently taking gastric acid inhibitors (H2 receptor blockers, proton pump inhibitors)
  • 10.History of allergic reactions to any form of oral or intravenous iron preparations
  • 11.History of prior non-compliance with oral iron therapy on account of gastro-intestinal side effects
  • 12.Current use or use within last 6 months of immunosuppressive drug therapy
  • 13.Pregnancy or lactation, in case of females
  • 14.Life expectancy <1 year

Investigators

Sponsor
Dr Vivek Kumar

Similar Trials